An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of decitabine in the
treatment of myelodysplastic syndrome (name of a group of conditions that occur when the
blood-forming cells in the bone marrow are damaged) in Chinese patients.